Testing of a Mobile Web App to Decrease Posttraumatic Stress Symptoms in Women After Sexual Assault
NCT ID: NCT04334356
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2020-05-30
2022-11-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors
NCT06571513
Comparing Behavioral Therapies for Treating Adolescents With Post-Traumatic Stress Disorder Related to Sexual Abuse
NCT02148484
Cognitive Processing Therapy Versus Prolonged Exposure for Treating Women With Post-Traumatic Stress Disorder Brought on by Sexual Assault
NCT00239772
Integrated Intervention Post-Sexual Assault
NCT04724746
Evaluation of Web-Based CBT for Rape Victims
NCT02777294
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
App Intervention
All participants will receive the web app for prevention of posttraumatic stress.
Mobile Web App
App for preventing development of posttraumatic stress based on cognitive behavioral techniques.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile Web App
App for preventing development of posttraumatic stress based on cognitive behavioral techniques.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receive a sexual assault nurse examiner (SANE) exam
* Alert and oriented
Exclusion Criteria
* Prisoners
* Pregnant women
* Women living with assailant who plan to continue living with assailant
* Women with fractures from the assault
* Admitted patients
* Women who do not have a smartphone with continuous service for the past 12 months
* Inability to read and speak English
* No mailing address
* SANE exam took place \>72 hours ago
* Patient previously enrolled in the study
18 Years
99 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicole Short, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Nevada, Las Vegas
Samuel McLean, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCHealth Memorial Central Hospital
Colorado Springs, Colorado, United States
University of North Carolina at Chapel Hill, SANE Program
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB. Advances in Patient-Reported Outcomes: The NIH PROMIS((R)) Measures. EGEMS (Wash DC). 2013 Aug 2;1(1):1015. doi: 10.13063/2327-9214.1015. eCollection 2013.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-3399
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.